EUVIMEDAtrasti EUVIMED
Video/Audio

Establishment of a TGF-β-Induced Rodent Myopia Model Using Subconjunctival Injections

Ying-Chi Chen, Yu-An Hsu, Chen-Hao Chen, Yung-Lan Chou, Jeng-Rung Chen, Lei Wan

Journal of Visualized Experiments · 2026

DOI: 10.3791/73178 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Ying-Chi Chen and 5 co-authors. Institution: Department of Veterinary Medicine, National Chung-Hsing University. Major MEDLINE topics: Disease Models, Animal, Myopia, Transforming Growth Factor beta2, Transforming Growth Factor beta.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Myopia is a major global public health concern characterized by excessive axial elongation and scleral extracellular matrix (ECM) remodeling. While experimental models are essential for investigating these mechanisms, traditional optical defocus methods in small rodents present technical limitations. Here, a standardizable pharmacological myopia model was established and evaluated via repeated subconjunctival injections of transforming growth factor-beta (TGF-β). To achieve targeted delivery, a dual-handed surgical stabilization technique was developed to evert the upper eyelid, allowing a 33-gauge needle to target the palpebral conjunctiva at a shallow 20°-30° angle. Through in vivo screening in rats, TGF-β2 (500 pg/eye) was identified as a prominent driver of posterior eye growth. Subsequent dose-response titration in mice revealed an inverted U-shaped profile. In the primary validation cohort, the lowest dose (250 pg/eye) induced pronounced axial elongation (0.197 ± 0.012 mm) and myopic refractive shifts (-1.58 ± 0.63 D). At the molecular level, repetitive TGF-β2 administration activated the retinal NOD-like receptor family pyrin domain-containing 3 (NLRP3) / interleukin-1β (IL-1β) inflammasome cascade and upregulated matrix metalloproteinase 2 (MMP2) expression in both species. Coupled with a two-day split biometric recording regimen that minimizes anesthesia-associated artifacts, this protocol provides a reliable, scalable platform for evaluating anti-myopia interventions.

Subjects

MeSH terms (MEDLINE)

Disease Models, AnimalMyopiaTransforming Growth Factor beta2Transforming Growth Factor betaAnimalsRatsMiceConjunctivaMaleRats, Sprague-Dawley

Substances

Transforming Growth Factor beta2Transforming Growth Factor beta

Authors and institutions

  • Department of Veterinary Medicine, National Chung-Hsing University.
  • School of Chinese Medicine, China Medical University.
  • Department of Chemistry, National Central University.
  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University.
  • Department of Veterinary Medicine, National Chung-Hsing University; chenjr@dragon.nchu.edu.tw.
  • Department of Obstetrics and Gynecology, China Medical University Hospital; leiwan@cmu.edu.tw.

Cite

APA

Chen, Y. C., Hsu, Y. A., Chen, C. H., Chou, Y. L., Chen, J. R., & Wan, L. (2026). Establishment of a TGF-β-Induced Rodent Myopia Model Using Subconjunctival Injections. Journal of Visualized Experiments. https://doi.org/10.3791/73178

Vancouver

Chen YC, Hsu YA, Chen CH, Chou YL, Chen JR, Wan L. Establishment of a TGF-β-Induced Rodent Myopia Model Using Subconjunctival Injections. Journal of Visualized Experiments. 2026. doi:10.3791/73178

BibTeX
@article{Chen2026,
  author = {Chen, Ying-Chi and Hsu, Yu-An and Chen, Chen-Hao and Chou, Yung-Lan and Chen, Jeng-Rung and Wan, Lei},
  title = {Establishment of a TGF-β-Induced Rodent Myopia Model Using Subconjunctival Injections},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/73178}
}
Start for free →